Newsletter | February 24, 2025

02.24.25 -- How To Best Optimize mRNA Production Workflows

SPONSOR

Join Advancing RNA Live for a deep dive into mRNA-LNP development, tackling key CQAs, manufacturing challenges, and the need for innovation in analytics, PAT, automation, and more. Explore strategies to enhance quality at smaller scales and navigate the future of advanced manufacturing. Reserve your spot for this free digital event happening March 13th!

SOLUTIONS

Thermal Ramping Characterization Solution: Aurora TX

Unlock automated, precise biomolecular structure measurements from a single drop. Gain cleaner, faster, more critical insights into your biomolecules with this innovative solution.

Request Information

RedShiftBio

Non-Viral Gene Delivery (NVGD) Using Polymeric-Nano Particles

Examine a NVGD platform that tackles the primary obstacle hindering gene editing therapies: efficient delivery. Utilizing engineered nanoparticles, the platform overcomes limitations associated with payload size.

Request Information

Battelle

TakeOne Aseptic Sampling System

The TakeOne is a single-use, pre-assembled sampling device for aseptic collection of samples during upstream and downstream process steps. It is ideal for critical endotoxin, bioburden, sterility and purity checks.

Request Information

Sartorius

Services For Advancing mRNA-LNPs From Bench To Clinic

Discover a one-stop-shop for LNP technologies that provides access to expertise in formulation and analytics for successful outcomes for payload and target applications. Explore end-to-end biopharma services and systems.

Request Information

Cytiva

How To Best Optimize mRNA Production Workflows

Multiple steps in the mRNA manufacturing process can appear more complex than they have to be. Learn how to simplify your approach and produce the best possible mRNA vaccines and therapeutics.

Request Information

Cytiva

mRNA Raw Materials: A Clear Path To Market

Design your mRNA manufacturing process with the certainty of fit-for-purpose standards for raw materials.

Request Information

Roche CustomBiotech

Enabling Capabilities And Solutions For All mRNA (Nucleic Acid) Platforms

Trust an experienced and trustworthy partner who understands the varying challenges you face and helps you solve them efficiently, safely and speedily.

Request Information

MilliporeSigma

INDe sgRNAs For Preclinical Safety, Toxicity, And Efficacy Studies

Seamlessly transition from discovery to delivery with INDe sgRNAs. These quality sgRNAs can be synthesized in quantities from milligrams to grams and follow high purity specifications.

Request Information

Synthego Corporation

Oligonucleotide Synthesizer

Synthesize oligonucleotides at scales of 10–100 mmol for early to mid-phase clinical trials or for diagnostic kits.

Request Information

Cytiva

Nanoparticle Enabled Formulation And Drug Delivery Solutions

Uncover how environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.

Request Information

Nanoform

De-Risk mRNA Regulatory Approvals

Gain insight into how you can de-risk mRNA regulatory approvals with critical quality attribute characterization and lot release testing.

Request Information

MilliporeSigma

Oligonucleotide Synthesis Solutions

Discover innovative approaches to oligonucleotide synthesis, showcasing their superior performance compared to traditional liquid chromatography methods.

Request Information

KNAUER

Early Phase Trials In Australia

Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.

Request Information

Novotech

Measure Quality Attributes Faster mRNA And LNP Analytical Services

Accelerate your drug discovery and development process by leveraging comprehensive quality insights for faster and more effective results.

Request Information

Vernal Biosciences